One-hoUr Troponin Using a High-sensitivity Point-Of-Care Assay in Emergency Primary Care

NARecruitingINTERVENTIONAL
Enrollment

2,500

Participants

Timeline

Start Date

June 27, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2029

Conditions
Acute Myocardial Infarction (AMI)Chest PainAcute Coronary Syndromes (ACS)Non-cardiac Chest PainTroponinPoint of Care TestingOut-of-hours Medical CarePrimary Care
Interventions
DIAGNOSTIC_TEST

QuidelOrthos TriageTrue hs-cTnI whole-blood assay

Already described

Trial Locations (6)

Unknown

RECRUITING

Lyngen Emergency Primary Care Centre, Lyngseidet

NOT_YET_RECRUITING

Alta Emergency Primary Care Centre, Alta

NOT_YET_RECRUITING

Drammen Emergency Primary Care Centre, Drammen

NOT_YET_RECRUITING

Fredrikstad and Hvaler Emergency Primary Care Centre, Fredrikstad

RECRUITING

Oslo Accident and Emergency Outpatient Clinic, Oslo

NOT_YET_RECRUITING

Trondheim Intermunicipal Emergency Primary Care Centre, Trondheim

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Norwegian Health Association

OTHER

collaborator

Oslo University Hospital

OTHER

collaborator

QuidelOrtho

INDUSTRY

collaborator

Vestre Viken Hospital Trust

OTHER

collaborator

The Dam Foundation

OTHER

collaborator

Amsterdam UMC

OTHER

collaborator

Sørlandet Hospital

UNKNOWN

lead

University of Oslo

OTHER

NCT06853626 - One-hoUr Troponin Using a High-sensitivity Point-Of-Care Assay in Emergency Primary Care | Biotech Hunter | Biotech Hunter